nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

27.01.2024 | Editorial

The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today

verfasst von: Daniela-Elena Oprea-Lager, Steven MacLennan, Rudi Dierckx, Stefano Fanti

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Excerpt

After three years of COVID-pandemic, and in that setting an once postponed and eventually cancelled European Association of Nuclear medicine (EANM) Focus 4 on molecular imaging and therapy in haematological tumours [1], the Nuclear Medicine community felt the longing for a live consensus meeting, with multidisciplinary stakeholders. As the clinical evidence was pointing to Theranostics in prostate cancer to be the most dynamic and rapidly evolving field in Oncology in the past 5 years, the choice for a new focus topic was obvious. …

Nanni C, Kobe C, Baeßler B, Baues C, Boellaard R, et al. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. Lancet Haematol. 2023;10(5):e367–81. https://doi.org/10.1016/S2352-3026(23)00030-3.CrossRefPubMed

Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, et al. Consensus on molecular imaging and theranostics in prostate cancer. Consensus on molecular imaging and theranostics in prostate cancer. Lancet Oncol. 2018;19(12):e696–708. https://doi.org/10.1016/S1470-2045(18)30604-1.CrossRefPubMed

Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias. Lancet Neurol. 2020;19:951–62. https://doi.org/10.1016/S1474-4422(20)30314-8.CrossRefPubMed

Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, et al. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. EJC. 2021;146:56–73. https://doi.org/10.1016/j.ejca.2021.01.008.CrossRef

Oprea-Lager DE, MacLennan S, Bjartell A, Alberto Briganti A, Burger IA, et al. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer. Eur Urol. 2023;S0302–2838(23):03092. https://doi.org/10.1016/j.eururo.2023.09.003.CrossRef

Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https://doi.org/10.1016/j.jbi.2019.103208.CrossRefPubMedPubMedCentral

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81. https://doi.org/10.1016/j.jbi.2008.08.010.CrossRefPubMed

Turpin A, Girard E, Baillet C, et al. Imaging for metastasis in prostate cancer: a review of the literature. Front Oncol. 2020;10:55. https://doi.org/10.3389/fonc.2020.00055.CrossRefPubMedPubMedCentral

Huo H, Shen S, He D, Liu B, Yang F. Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-tohead comparison studies. Prostate Cancer Prostatic Dis. 2023;26:16–24. https://doi.org/10.1038/s41391-022-00581-y.CrossRefPubMed

10.

Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTROESUR- SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243–62. https://doi.org/10.1016/j.eururo.2020.09.042.CrossRefPubMed

11.

Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTROESUR- SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021;79:263–82. https://doi.org/10.1016/j.eururo.2020.09.046.CrossRefPubMed

Titel: The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today
verfasst von: Daniela-Elena Oprea-Lager
Steven MacLennan
Rudi Dierckx
Stefano Fanti
Publikationsdatum: 27.01.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2024
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-023-06552-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2024

Comparative assessment of radiation therapy–induced vasculitis using [18F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy

[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica

EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials

Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT

A convolutional neural network–based system for fully automatic segmentation of whole-body [68Ga]Ga-PSMA PET images in prostate cancer

Effects of medication on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice